Liwei Meng

518 total citations
20 papers, 388 citations indexed

About

Liwei Meng is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Liwei Meng has authored 20 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Liwei Meng's work include Extracellular vesicles in disease (4 papers), MicroRNA in disease regulation (4 papers) and Circular RNAs in diseases (4 papers). Liwei Meng is often cited by papers focused on Extracellular vesicles in disease (4 papers), MicroRNA in disease regulation (4 papers) and Circular RNAs in diseases (4 papers). Liwei Meng collaborates with scholars based in China, Taiwan and United States. Liwei Meng's co-authors include Yingchun Xu, He Sun, Shan Hu, Liming Huang, Li‐Min Huang, Zhaoxu Liu, Zhaoquan Xing, Zhaoxin Guo, Wei Zhang and Yue Qiu and has published in prestigious journals such as Medicine, Cell Death and Disease and Frontiers in Oncology.

In The Last Decade

Liwei Meng

18 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liwei Meng China 10 222 121 92 48 40 20 388
Yingchun Xu China 9 214 1.0× 70 0.6× 92 1.0× 59 1.2× 41 1.0× 22 397
Vetriselvan Subramaniyan India 12 227 1.0× 128 1.1× 42 0.5× 34 0.7× 28 0.7× 38 500
Vinod Vijayakurup India 12 197 0.9× 54 0.4× 73 0.8× 36 0.8× 38 0.9× 17 375
Mayrel Palestino Domínguez Mexico 9 201 0.9× 81 0.7× 93 1.0× 99 2.1× 15 0.4× 13 439
Min-Ting Lin China 8 301 1.4× 147 1.2× 51 0.6× 48 1.0× 21 0.5× 8 448
Chengwu Shen China 11 179 0.8× 63 0.5× 51 0.6× 70 1.5× 35 0.9× 28 421
Binqiang Tian China 11 268 1.2× 91 0.8× 95 1.0× 70 1.5× 13 0.3× 14 497
Fardin Hashemi Iran 8 351 1.6× 173 1.4× 109 1.2× 97 2.0× 20 0.5× 9 601
Zeinab Khazaei Koohpar Iran 10 246 1.1× 87 0.7× 54 0.6× 35 0.7× 12 0.3× 40 433

Countries citing papers authored by Liwei Meng

Since Specialization
Citations

This map shows the geographic impact of Liwei Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liwei Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liwei Meng more than expected).

Fields of papers citing papers by Liwei Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liwei Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liwei Meng. The network helps show where Liwei Meng may publish in the future.

Co-authorship network of co-authors of Liwei Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Liwei Meng. A scholar is included among the top collaborators of Liwei Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liwei Meng. Liwei Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shi, Mengya, et al.. (2025). Plant-derived extracellular vesicles as a novel tumor-targeting delivery system for cancer treatment. Frontiers in Cell and Developmental Biology. 13. 1589550–1589550. 1 indexed citations
3.
4.
Che, Qian, et al.. (2023). Spatial–temporal pattern of urban ecological construction in the Yellow River basin and its optimization and promotion paths. Frontiers in Ecology and Evolution. 11. 2 indexed citations
5.
Qian, Da, et al.. (2023). Circulating tumor biomarkers in early-stage breast cancer: characteristics, detection, and clinical developments. Frontiers in Oncology. 13. 1288077–1288077. 10 indexed citations
6.
Li, Richard, et al.. (2023). Arrhythmia classification method based on knowledge distillation and 2D ECG images. 493–497. 1 indexed citations
7.
Liu, Tianyu, Xiaolin Hu, Kewei Li, et al.. (2022). Case report: An ectopic adrenocortical adenoma in the renal sinus. Frontiers in Oncology. 12. 934862–934862. 2 indexed citations
8.
Meng, Liwei, et al.. (2022). Effect of reduction pretreatments on PdAg/Al2O3 for HCHO and CO oxidation. Journal of Environmental Sciences. 124. 371–378. 4 indexed citations
9.
Meng, Liwei, Zhaoquan Xing, Zhaoxin Guo, Yue Qiu, & Zhaoxu Liu. (2021). Hypoxia-induced microRNA-155 overexpression in extracellular vesicles promotes renal cell carcinoma progression by targeting FOXO3. Aging. 13(7). 9613–9626. 29 indexed citations
10.
Hu, Guoming, Liming Huang, Liwei Meng, et al.. (2021). PDGFR-β+ fibroblasts deteriorate survival in human solid tumors: a meta-analysis. Aging. 13(10). 13693–13707. 11 indexed citations
11.
12.
Meng, Liwei, et al.. (2020). LINC00689 promotes prostate cancer progression via regulating miR-496/CTNNB1 to activate Wnt pathway. Cancer Cell International. 20(1). 215–215. 13 indexed citations
13.
Meng, Liwei, Zhaoquan Xing, Zhaoxin Guo, & Zhaoxu Liu. (2020). LINC01106 post-transcriptionally regulates ELK3 and HOXD8 to promote bladder cancer progression. Cell Death and Disease. 11(12). 1063–1063. 33 indexed citations
14.
Meng, Liwei, et al.. (2019). Incidence of interstitial pneumonitis in breast cancer patients treated with pegylated liposomal doxorubicin. Cancer Chemotherapy and Pharmacology. 85(1). 3–7. 4 indexed citations
15.
Dong, Zhaogang, Xiaoyan Sun, Jingjing Xu, et al.. (2019). Serum Membrane Type 1-Matrix Metalloproteinase (MT1-MMP) mRNA Protected by Exosomes as a Potential Biomarker for Gastric Cancer. Medical Science Monitor. 25. 7770–7783. 27 indexed citations
16.
Hu, Shan, Yingchun Xu, Liwei Meng, Liming Huang, & He Sun. (2018). Curcumin inhibits proliferation and promotes apoptosis of breast cancer cells. Experimental and Therapeutic Medicine. 16(2). 1266–1272. 155 indexed citations
17.
Hu, Shan, Li‐Min Huang, Liwei Meng, et al.. (2015). Isorhamnetin inhibits cell proliferation and induces apoptosis in breast cancer via Akt and mitogen-activated protein kinase kinase signaling pathways. Molecular Medicine Reports. 12(5). 6745–6751. 72 indexed citations
18.
Meng, Liwei, Shan Hu, Li‐Min Huang, & Chaoyang Xu. (2014). Papillary thyroid cancer coexisting with thyroid tuberculosis: A case report. Oncology Letters. 7(5). 1563–1565. 11 indexed citations
19.
Meng, Liwei, Li‐Min Huang, Chaoyang Xu, & Wei Zhang. (2012). [Managements of small thyroid nodules with contralateral papillary thyroid microcarcinoma].. PubMed. 47(10). 827–30. 1 indexed citations
20.
Meng, Liwei, Li‐Min Huang, & Wei Chen. (2011). [Horner's syndrome after central neck dissection in thyroid cancer: two cases report].. PubMed. 46(6). 516–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yingchun Xu Breakdown of academic impact, for papers by Vetriselvan Subramaniyan Breakdown of academic impact, for papers by Vinod Vijayakurup Breakdown of academic impact, for papers by Mayrel Palestino Domínguez Breakdown of academic impact, for papers by Min-Ting Lin Breakdown of academic impact, for papers by Chengwu Shen Breakdown of academic impact, for papers by Binqiang Tian Breakdown of academic impact, for papers by Fardin Hashemi Breakdown of academic impact, for papers by Zeinab Khazaei Koohpar
Rankless by CCL
2026